EUVIMEDEUVIMED entdecken
Crossref

Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria

Diana Averbuch, Liya Moshkovitz, Shlomi Ilan, Wiessam Abu Ahmad, Violeta Temper, Jacob Strahilevitz iD

Microbial Drug Resistance · 01.05.2022 · 28 (5) · 593-600

DOI: 10.1089/mdr.2021.0253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Drug Resistance, online erschienen am 17.05.2022. Verfasst von Diana Averbuch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Infectious Diseases, Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: Bacteremia, Enterobacteriaceae Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to analyze rates and risk factors for carbapenemase-producing Enterobacterales (CPE) bloodstream infection (BSI) in CPE-colonized patients with malignancies or following hematopoietic cell transplantation. We retrospectively collected data on demography, underlying disease, colonizing CPE, treatment, intensive care unit (ICU) hospitalization, CPE-BSI, and mortality in CPE-colonized immunocompromised patients (2014–2020). Two hundred twenty-one patients were colonized with 272 CPE: 254 (93.4%) carried one carbapenemase [KPC (50.4%), NDM (34.6%), OXA-48-like (5.2%), and VIM (3.3%)]; 18 (6.6%) carried two carbapenemases. Twenty-eight (12.7%) patients developed CPE-BSI. Univariate analysis revealed CPE-BSI-associated factors: younger age, carbapenem or aminoglycoside exposure, ICU admission, neutropenia, carrying serine carbapenemase-producing, and specifically KPC-producing bacteria, colonization with several CPE, and detection of several carbapenemases. None of 23 auto-HSCT recipients developed CPE-BSI. In multivariate analysis, ICU hospitalization was significantly associated with CPE-BSI (odds ratio [OR] 2.82, 95% CI 1.10–7.20; p = 0.042); solid tumor diagnosis was protective (OR 0.21, 95% CI 0.05–1.01; p = 0.038). One-year crude mortality was 108/221 (48.8%), including 19/28 (67.9%) and 89/193 (46.1%) in patients with and without CPE-BSI, p = 0.104. To conclude, CPE-BSI is rare in CPE-colonized patients with solid tumors and following auto-HSCT. ICU hospitalization increased CPE-BSI risk. These data can help to guide empirical anti-CPE antibiotic therapy in patients colonized with these bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaEnterobacteriaceae InfectionsAnti-Bacterial AgentsBacterial ProteinsHumansImmunocompromised HostRetrospective Studiesbeta-Lactamases

Stichwörter der Autor:innen

bacteremiacancercarbapenem-resistant Enterobacteralescolonizationhematopoietic stem cell transplantation

Substanzen

Anti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemase

Autor:innen und Institutionen

  • Pediatric Infectious Diseases, Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel.
  • Braun School of Public Health and Community Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Department of Clinical Microbiology and Infectious Diseases, Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel.

ORCID-Profile: Jacob Strahilevitz

Zitieren

APA

Averbuch, D., Moshkovitz, L., Ilan, S., Abu Ahmad, W., Temper, V., & Strahilevitz, J. (2022). Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria. Microbial Drug Resistance, 28(5), 593-600. https://doi.org/10.1089/mdr.2021.0253

Vancouver

Averbuch D, Moshkovitz L, Ilan S, Abu Ahmad W, Temper V, Strahilevitz J. Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria. Microbial Drug Resistance. 2022;28(5):593-600. doi:10.1089/mdr.2021.0253

BibTeX
@article{Averbuch2022,
  author = {Averbuch, Diana and Moshkovitz, Liya and Ilan, Shlomi and Abu Ahmad, Wiessam and Temper, Violeta and Strahilevitz, Jacob},
  title = {Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria},
  journal = {Microbial Drug Resistance},
  year = {2022},
  volume = {28},
  number = {5},
  pages = {593--600},
  doi = {10.1089/mdr.2021.0253}
}
Kostenlos starten →